Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase 3

SURTIME

Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer

  • NCT01099423 ↗
  • Unknown
  • European Organisation for Research and Treatment of Cancer - EORTC
  • Standard

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Preliminary discovery

Commentary in our index that names this trial so far

Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.

ChannelFound
X threads10
Podcasts4
YouTube3

The trial

ClinicalTrials.gov
Official title
Randomized Phase III Trial Comparing Immediate Versus Deferred Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma
Phase
Phase 3
Status
Unknown
Conditions
Kidney Cancer
Interventions
timing of surgery; gene expression analysis; biologic sample preservation procedure; laboratory biomarker analysis; therapeutic conventional surgery
Arms
  • Immediate nephrectomy · Active comparator
  • Deferred nephrectomy · Experimental
Enrollment
99
Primary outcomes
  • Overall progression-free survival
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC with Wales Cancer Trials Unit, Canadian Urologic Oncology Group, Institute of Cancer Research, United Kingdom
Start
Apr 2010
Primary completion
Apr 2016
Results posted
No
Registry record
NCT01099423 · updated Feb 8, 2017

Publications

linked from the registry
  • Bex A, Mulders P, Jewett M, Wagstaff J, van Thienen JV, Blank CU, van Velthoven R, Del Pilar Laguna M, Wood L, van Melick HHE, Aarts MJ, Lattouf JB, Powles T, de Jong Md PhD IJ, Rottey S, Tombal B, Marreaud S, Collette S, Collette L, Haanen J. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial. JAMA Oncol. 2019 Feb 1;5(2):164-170. doi: 10.1001/jamaoncol.2018.5543. PubMed 30543350
  • Leon L, Garcia-Figueiras R, Suarez C, Arjonilla A, Puente J, Vargas B, Mendez Vidal MJ, Sebastia C. Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer. Target Oncol. 2014 Mar;9(1):9-24. doi: 10.1007/s11523-013-0304-7. Epub 2013 Dec 12. PubMed 24338498
  • Winquist E, Rodrigues G. Open clinical uro-oncology trials in Canada. Can J Urol. 2012 Dec;19(6):6587-91. No abstract available. PubMed 23228299